278 related articles for article (PubMed ID: 31743110)
1. BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults.
Rakshit S; Ahmed A; Adiga V; Sundararaj BK; Sahoo PN; Kenneth J; D'Souza G; Bonam W; Johnson C; Franken KL; Ottenhoff TH; Finak G; Gottardo R; Stuart KD; De Rosa SC; McElrath MJ; Vyakarnam A
JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31743110
[TBL] [Abstract][Full Text] [Related]
2. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses.
Suliman S; Geldenhuys H; Johnson JL; Hughes JE; Smit E; Murphy M; Toefy A; Lerumo L; Hopley C; Pienaar B; Chheng P; Nemes E; Hoft DF; Hanekom WA; Boom WH; Hatherill M; Scriba TJ
J Immunol; 2016 Aug; 197(4):1100-1110. PubMed ID: 27412415
[TBL] [Abstract][Full Text] [Related]
3. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity.
Rai PK; Chodisetti SB; Zeng W; Nadeem S; Maurya SK; Pahari S; Janmeja AK; Jackson DC; Agrewala JN
J Transl Med; 2017 Oct; 15(1):201. PubMed ID: 28985739
[TBL] [Abstract][Full Text] [Related]
4. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
5. Clofazimine enhances the efficacy of BCG revaccination via stem cell-like memory T cells.
Ahmad S; Bhattacharya D; Gupta N; Rawat V; Tousif S; Van Kaer L; Das G
PLoS Pathog; 2020 May; 16(5):e1008356. PubMed ID: 32437421
[TBL] [Abstract][Full Text] [Related]
6. A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin.
Woodworth JS; Clemmensen HS; Battey H; Dijkman K; Lindenstrøm T; Laureano RS; Taplitz R; Morgan J; Aagaard C; Rosenkrands I; Lindestam Arlehamn CS; Andersen P; Mortensen R
Nat Commun; 2021 Nov; 12(1):6658. PubMed ID: 34795205
[TBL] [Abstract][Full Text] [Related]
7. Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.
Pitt JM; Stavropoulos E; Redford PS; Beebe AM; Bancroft GJ; Young DB; O'Garra A
J Immunol; 2012 Oct; 189(8):4079-87. PubMed ID: 22972927
[TBL] [Abstract][Full Text] [Related]
8. A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.
da Costa AC; Costa-Júnior Ade O; de Oliveira FM; Nogueira SV; Rosa JD; Resende DP; Kipnis A; Junqueira-Kipnis AP
PLoS One; 2014; 9(11):e112848. PubMed ID: 25398087
[TBL] [Abstract][Full Text] [Related]
9. The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG.
Satchidanandam V; Kumar N; Jumani RS; Challu V; Elangovan S; Khan NA
PLoS Pathog; 2014 Jun; 10(6):e1004176. PubMed ID: 24945624
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
11. Recombinant BCG::Rv2645 elicits enhanced protective immunity compared to BCG in vivo with induced ISGylation-related genes and Th1 and Th17 responses.
Luo W; Qu Z; Zhang L; Xie Y; Luo F; Tan Y; Pan Q; Zhang XL
Vaccine; 2018 May; 36(21):2998-3009. PubMed ID: 29681409
[TBL] [Abstract][Full Text] [Related]
12. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
Abebe F
Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
[TBL] [Abstract][Full Text] [Related]
13. Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.
Burl S; Adetifa UJ; Cox M; Touray E; Ota MO; Marchant A; Whittle H; McShane H; Rowland-Jones SL; Flanagan KL
J Immunol; 2010 Aug; 185(4):2620-8. PubMed ID: 20644160
[TBL] [Abstract][Full Text] [Related]
14. CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial.
Masonou T; Hokey DA; Lahey T; Halliday A; Berrocal-Almanza LC; Wieland-Alter WF; Arbeit RD; Lalvani A; von Reyn CF
PLoS One; 2019; 14(5):e0217091. PubMed ID: 31120957
[TBL] [Abstract][Full Text] [Related]
15. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
[TBL] [Abstract][Full Text] [Related]
16. Intranasal boosting with MVA encoding secreted mycobacterial proteins Ag85A and ESAT-6 generates strong pulmonary immune responses and protection against M. tuberculosis in mice given BCG as neonates.
Khanna M; Rady H; Dai G; Ramsay AJ
Vaccine; 2021 Mar; 39(12):1780-1787. PubMed ID: 33632562
[TBL] [Abstract][Full Text] [Related]
17. Adolescent BCG revaccination induces a phenotypic shift in CD4
Dintwe OB; Ballweber Fleming L; Voillet V; McNevin J; Seese A; Naidoo A; Omarjee S; Bekker LG; Kublin JG; De Rosa SC; Newell EW; Fiore-Gartland A; Andersen-Nissen E; McElrath MJ
Nat Commun; 2024 Jun; 15(1):5191. PubMed ID: 38890283
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity.
Kleinnijenhuis J; Quintin J; Preijers F; Benn CS; Joosten LA; Jacobs C; van Loenhout J; Xavier RJ; Aaby P; van der Meer JW; van Crevel R; Netea MG
J Innate Immun; 2014; 6(2):152-8. PubMed ID: 24192057
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques.
Sarfas C; White AD; Sibley L; Morrison AL; Gullick J; Lawrence S; Dennis MJ; Marsh PD; Fletcher HA; Sharpe SA
Front Immunol; 2021; 12():754589. PubMed ID: 34707617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
